Form 4: Novavax Director Margaret McGlynn Reports Stock Transactions
SEC Form 4
Director Margaret McGlynn reports the acquisition and disposal of Novavax stock and derivative securities.
Summary
- On June 12, 2024, Margaret McGlynn, a director of Novavax Inc., reported transactions involving the company's stock.
- McGlynn disposed of 6,670 shares of Common Stock.
- McGlynn also acquired 15,630 Stock Options (Right to Buy) with an exercise price of $15.86, exercisable from June 12, 2025, to June 12, 2034.
- Additionally, McGlynn acquired 10,420 Restricted Stock Units, exercisable from June 12, 2025, to June 12, 2034.
- Following these transactions, McGlynn directly owns 15,630 Stock Options and 10,420 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of company directors.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the director's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of earliest transaction: disposal of common stock and acquisition of stock options and restricted stock units. |
| 06/12/2025 | Date from which Stock Options and Restricted Stock Units become exercisable. |
| 06/12/2033 | Expiration date for Restricted Stock Units. |
| 06/12/2034 | Expiration date for Stock Options. |
| 06/14/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.